DHS Medical is committed to develop treatments for improving the quality of life of patients with Diastolic Heart Failure.
3 Million patients in the US suffer from Diastolic Heart Failure. Currently there is no specific therapy for DHF.
DHS Medical develops a proprietary implantable medical device (IMD) that evaluates in real-time the filling pattern of the left ventricle. Based on the measured data, we can provide on-demand increasing cardiac output, which we believe would enable patients to perform greater physical tasks and avoid hospitalizations.